Cannara Biotech8CB0 
$0.44-5.66%24h
-5.66%24h
Global rank26472
Market cap$39.70M
Change 7d-5.21%
YTD Performance-27.93%
SP500 benchmarkUnderperform
P/E5.56
P/S0.94
Revenue$42.06M
Earnings$5.10M
Dividend yield-
Main Sector
Healthcare
Cannara Biotech 8CB0 Operating Margins
Operating Margin in 2022: 0.21%
According to Cannara Biotech latest financial reports the company has an operating margin of 0.21%, an increase of 51.22% to 2022. At the end of 2022 company had an operating margin of 0.14%.
Cannara Biotech Operating Margin from 2020 to 2024
-
Value:-
8CB0 Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 0.21% | 51.22% |
| 2022 | 0.14% | 689.72% |
| 2021 | 0.02% | -100.38% |
| 2020 | -4.68% | - |
View the highest operating margin companies 
